Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
Arjun Law(University of Toronto), Auro Viswabandya(Princess Margaret Cancer Centre), Rajat Kumar(University Health Network), Santhosh Thyagu(Princess Margaret Cancer Centre), Fotios V. Michelis(Princess Margaret Cancer Centre), Dennis Dong Hwan Kim(University Health Network), Wilson Lam(Princess Margaret Cancer Centre), Jeffrey H. Lipton(Princess Margaret Cancer Centre), Hans A. Messner(University of Toronto), María Queralt Salas(Canary Institute of Cancer Research)
Cited by 92
Related Papers
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2010|1k
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
|Cancer Cell|2014|366
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
|Leukemia|2008|354
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy
|Oncotarget|2017|187
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD
|Bone Marrow Transplantation|2020|59